Livforsakringsbolaget Skandia’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-14,610
Closed -$2.78M 697
2018
Q3
$2.78M Sell
14,610
-5,200
-26% -$955K 0.33% 84
2018
Q2
$3.3M Buy
19,810
+900
+5% +$144K 0.3% 93
2018
Q1
$3.18M Hold
18,910
0.31% 94
2017
Q4
$3.09M Sell
18,910
-2,700
-12% -$485K 0.3% 95
2017
Q3
$4.43M Sell
21,610
-300
-1% -$69.8K 0.4% 63
2017
Q2
$5.33M Hold
21,910
0.49% 49
2017
Q1
$5.24M Sell
21,910
-17,100
-44% -$3.98M 0.49% 49
2016
Q4
$8.19K Buy
39,010
+16,522
+73% +$3.42M 0.42% 43
2016
Q3
$4.42M Sell
22,488
-29,022
-56% -$7.09M 0.22% 111
2016
Q2
$11.9M Buy
51,510
+3,300
+7% +$761K 0.53% 40
2016
Q1
$12.9M Hold
48,210
0.61% 37
2015
Q4
$15.1M Buy
48,210
+2,900
+6% +$863K 0.71% 31
2015
Q3
$12.3M Hold
45,310
0.65% 31
2015
Q2
$13.8M Buy
45,310
+2,900
+7% +$865K 0.67% 28
2015
Q1
$12.6M Buy
42,410
+9,313
+28% +$2.66M 0.62% 31
2014
Q4
$8.52M Sell
33,097
-10,700
-24% -$2.67M 0.4% 50
2014
Q3
$10.6M Buy
43,797
+11,554
+36% +$2.59M 0.4% 48
2014
Q2
$7.19M Hold
32,243
0.26% 90
2014
Q1
$6.64M Buy
32,243
+25,455
+375% +$5.04M 0.25% 96
2013
Q4
$1.14M Buy
6,788
+5,088
+299% +$795K 0.74% 46
2013
Q3
$245K Hold
1,700
0.17% 130
2013
Q2
$215K Buy
+1,700
New +$192K 0.15% 132

Other funds holding AGN

Livforsakringsbolaget Skandia's AGN Position: Q4 2018 in Review

Livforsakringsbolaget Skandia sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 14,610 shares — an estimated $2.78M sold.

Livforsakringsbolaget Skandia first reported a position in AGN in Q2 2013 and held it in 22 quarters. The position peaked at $15.1M in Q4 2015. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Livforsakringsbolaget Skandia reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Livforsakringsbolaget Skandia sold 14,610 Allergan plc shares in Q4 2018, an estimated $2.78M.
  • Livforsakringsbolaget Skandia first reported a position in Allergan plc in Q2 2013 and held it in 22 quarters.
  • Livforsakringsbolaget Skandia's Allergan plc position peaked at $15.1M in Q4 2015.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Livforsakringsbolaget Skandia's 13F filing for Q4 2018, filed 6 Feb 2019.